iiinova — where your digital self keeps evolving

MariSubklewe

@msubklewe.bsky.social

Interested in T cells, T cell exhaustion, T cell engagers, CAR T cells, CPI, AML, ALL, Lumphoma, PTLD, but also in running, hiking, tennis, classical music, opera and traveling !

Posts Replies Media

Reposted by MariSubklewe

Gene Center Munich @LMU Munich @genecenter-lmu.bsky.social · 05/03/2026

📣 @msubklewe.bsky.social and Veit Bücklein lead EASE-AML, a novel cell therapy for aggressive leukemia👏 Funded with €3 million, ERASE-AML is one of the two newly launched clinical trials supported by the Bavarian Cancer Research Center (BZKF). Congratulations, Marion!🥂🥳

The Bavarian State Minister for Science, Markus Blume, symbolically presents Prof. Marion Subklewe with a check for €3 million. The funding will support ERASE-ML, the first clinical trial financed by the Bavarian Cancer Research Center (BZKF).

031

Reposted by MariSubklewe

Gene Center Munich @LMU Munich @genecenter-lmu.bsky.social · 13/11/2025

🥳 Veit Hornung, Marion Subklewe and Christoph Klein are again among the most influential researchers. Congratulations! 🤩 @v-hornung.bsky.social @msubklewe.bsky.social @lmumuenchen.bsky.social

1101

Reposted by MariSubklewe

Gene Center Munich @LMU Munich @genecenter-lmu.bsky.social · 29/01/2026

🌟Don' t miss this article about personalized cancer therapy featuring our PI, Marion Subklewe www.lmu.de/en/about-lmu... @msubklewe.bsky.social

lmu.de

Cancer therapy made to measure

Marion Subklewe and Sebastian Kobold are getting the immune system to target tumors and opening up new perspectives for patient-specific treatments.

001

MariSubklewe @msubklewe.bsky.social · 24/05/2025

150+ women from all career stages came together at #FAME2025 – Females in Academic Medicine – at @LMU_Muenchen's Medical Faculty. A vibrant, strong space for exchange, inspiration & solidarity. Thanks to @WiebkeArlt, @AnnaFrebel & all who made it possible. #ConnectForChange

010

MariSubklewe @msubklewe.bsky.social · 21/11/2024

Excited to join this new platform ! Hoping for the scientific community to be part of this. Appreciated updates on immunotherapy in cancer on twitter - not a platform I like to support anymore. Happy to be in the group of most cited researchers at the LMU - Munich Germany. x.com/lmu_muenchen...

010